Eucrates Biomedical Acquisition Cor... (EUCR)

$10.1

0.00 (0.00%)
Rating:
Recommendation:
-
Symbol EUCR
Price $10.1
Beta -0.094
Volume Avg. 0.00M
Market Cap 42.481M
Shares () -
52 Week Range 9.803-10.1
1y Target Est -
DCF Unlevered EUCR DCF ->
DCF Levered EUCR LDCF ->
ROE -78.74% Strong Sell
ROA 3.20% Neutral
Operating Margin -
Debt / Equity -105.28% Sell
P/E 53.16 Strong Buy
P/B -28.34 Strong Sell
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Financial Services
Shell Companies
NASDAQ Capital Market

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.